Adelaide Research & Scholarship: Search

Search

Results 21-30 of 119 (Search time: 0.003 seconds).

previous
1
2
3
4
5
6
...
12
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	Novel IL1RAPL1 mutations associated with intellectual disability impair synaptogenesis	Ramos-Brossier, M.; Montani, C.; Lebrun, N.; Gritti, L.; Martin, C.; Seminatore-Nole, C.; Toussaint, A.; Moreno, S.; Poirier, K.; Dorseuil, O.; Chelly, J.; Hackett, A.; Gecz, J.; Bieth, E.; Faudet, A.; Heron, D.; Kooy, R.; Loeys, B.; Humeau, Y.; Sala, C.; et al.
	2009	The INeS study: Prevention of multiple pregnancies: A randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility	Bensdorp, A.; Slappendel, E.; Koks, C.; Oosterhuis, G.; Hoek, A.; Hompes, P.; Broekmans, F.; Verhoeve, H.; de Bruin, J.; van Weert, J.; Traas, M.; Maas, J.; Beckers, N.; Repping, S.; Mol, B.; van der Veen, F.; van Wely, M.
	2009	Immobilisation versus immediate mobilisation after intrauterine insemination: randomised controlled trial	Custers, I.; Flierman, P.; Maas, P.; Cox, T.; Van Dessel, T.; Gerards, M.; Mochtar, M.; Janssen, C.; van der Veen, F.; Mol, B.
	2016	Prenatal fish oil supplementation and allergy: 6-year follow-up of a randomized controlled trial	Best, K.P.; Sullivan, T.; Palmer, D.; Gold, M.; Kennedy, D.J.; Martin, J.; Makrides, M.
	2011	How can we teach EBM in clinical practice? An analysis of barriers to implementation of on-the-job EBM teaching and learning	Oude Rengerink, K.; Thangaratinam, S.; Barnfield, G.; Suter, K.; Horvath, A.; Walczak, J.; Welminska, A.; Weinbrenner, S.; Meyerrose, B.; Arvanitis, T.; Onody, R.; Zanrei, G.; Kunz, R.; Arditi, C.; Burnand, B.; Gee, H.; Khan, K.; Mol, B.
	2002	The risk of mortality or cerebral palsy in twins: A collaborative population-based study	Scher, A.; Petterson, B.; Blair, E.; Ellenberg, J.; Grether, J.; Haan, E.; Reddihough, D.; Yeargin-Allsopp, M.; Nelson, K.
	1996	Characterisation of four novel fibrillin-1 mutations in the Marfan syndrome	Ades, L.; Haan, E.; Colley, A.; Richards, R.
	2013	Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy	Braunlin, E.; Rosenfeld, H.; Kampmann, C.; Johnson, J.; Beck, M.; Giugliani, R.; Guffon, N.; Ketteridge, D.; Miranda, C.; Scarpa, M.; Schwartz, I.; Teles, E.; Wraith, J.; Barrios, P.; Dias da Silva, E.; Kurio, G.; Richardson, M.; Gildengorin, G.; Hopwood, J.; Imperiale, M.; et al.
	2015	Mutations in the intellectual disability gene KDM5C reduce protein stability and demethylase activity	Brookes, E.; Laurent, B.; Õunap, K.; Carroll, R.; Moeschler, J.; Field, M.; Schwartz, C.; Gecz, J.; Shi, Y.
	2002	Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation	Turner, G.; Partington, M.; Kerr, B.; Mangelsdorf, M.; Gecz, J.